Financials Petco Health and Wellness Company, Inc.

Equities

WOOF

US71601V1052

Other Specialty Retailers

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.51 USD 0.00% Intraday chart for Petco Health and Wellness Company, Inc. -9.04% -52.22%

Valuation

Fiscal Period: February 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 6,872 4,783 3,162 665.9 407.1 - -
Enterprise Value (EV) 1 8,409 6,259 4,611 2,133 1,784 1,689 1,481
P/E ratio -200 x 29.2 x 35 x -0.52 x -7.25 x 3,595 x -41.2 x
Yield - - - - - - -
Capitalization / Revenue 1.4 x 0.82 x 0.52 x 0.11 x 0.07 x 0.06 x 0.06 x
EV / Revenue 1.71 x 1.08 x 0.76 x 0.34 x 0.29 x 0.27 x 0.23 x
EV / EBITDA 17.4 x 10.6 x 7.92 x 5.32 x 5.21 x 4.41 x 3.62 x
EV / FCF 77.1 x 52.5 x 67.8 x -216 x 39.6 x 65 x 64.4 x
FCF Yield 1.3% 1.9% 1.47% -0.46% 2.52% 1.54% 1.55%
Price to Book 3.32 x 2.11 x 1.33 x - 0.26 x 0.27 x 0.27 x
Nbr of stocks (in thousands) 264,215 264,413 265,920 268,489 269,577 - -
Reference price 2 26.01 18.09 11.89 2.480 1.510 1.510 1.510
Announcement Date 3/18/21 3/8/22 3/22/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 4,435 4,920 5,807 6,036 6,255 6,132 6,314 6,453
EBITDA 1 - 484.3 591.5 582.3 401.1 342.4 382.7 409.4
EBIT 1 - 194.4 403.1 388.5 178.3 132.3 173.3 197
Operating Margin - 3.95% 6.94% 6.44% 2.85% 2.16% 2.75% 3.05%
Earnings before Tax (EBT) 1 - -41.6 202.4 112.3 -1,324 -116 -53.58 -22.14
Net income 1 -95.87 -26.48 164.4 90.8 -1,280 -62.05 -16.95 -9.346
Net margin -2.16% -0.54% 2.83% 1.5% -20.47% -1.01% -0.27% -0.14%
EPS 2 - -0.1300 0.6200 0.3400 -4.780 -0.2082 0.000420 -0.0366
Free Cash Flow 1 - 109.1 119.1 67.98 -9.879 45 25.98 23
FCF margin - 2.22% 2.05% 1.13% -0.16% 0.73% 0.41% 0.36%
FCF Conversion (EBITDA) - 22.52% 20.14% 11.67% - 13.14% 6.79% 5.62%
FCF Conversion (Net income) - - 72.44% 74.87% - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 10/2/20 3/18/21 3/8/22 3/22/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1
Net sales 1 1,443 1,514 1,476 1,481 1,501 1,578 1,556 1,531 1,494 1,674 1,515 1,519 1,503 1,592 1,575
EBITDA 1 138.5 172.2 132.6 142 137.6 170.3 111 112.6 72.16 105.3 69.33 81.52 78.64 108.2 80.75
EBIT 1 91.69 120.4 81.97 93.35 89.53 120 56.17 58.7 15.87 47.55 16.42 28.2 25.87 57.59 31.5
Operating Margin 6.35% 7.95% 5.55% 6.3% 5.96% 7.61% 3.61% 3.83% 1.06% 2.84% 1.08% 1.86% 1.72% 3.62% 2%
Earnings before Tax (EBT) 1 62.97 33.58 30.64 18.06 21.45 42.12 -6.03 -11.2 -1,268 -39.17 -42.61 -35.86 -32.05 -8.744 -24.26
Net income 1 52.75 28.99 24.69 13.46 19.92 32.73 -1.892 -14.61 -1,241 -22.58 -26.89 -21.35 -17.57 3.506 -14.12
Net margin 3.66% 1.91% 1.67% 0.91% 1.33% 2.07% -0.12% -0.95% -83.07% -1.35% -1.78% -1.41% -1.17% 0.22% -0.9%
EPS 2 0.2000 0.1100 0.0900 0.0500 0.2200 0.1200 -0.0100 -0.0500 -4.630 -0.0800 -0.0974 -0.0786 -0.0630 0.002530 -0.0310
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/18/21 3/8/22 5/24/22 8/24/22 11/30/22 3/22/23 5/24/23 8/24/23 11/29/23 3/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: February 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - 1,537 1,476 1,449 1,467 1,377 1,282 1,074
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - 3.174 x 2.495 x 2.489 x 3.657 x 4.021 x 3.35 x 2.622 x
Free Cash Flow 1 - 109 119 68 -9.88 45 26 23
ROE (net income / shareholders' equity) - -2.01% 7.57% 8.62% -71.8% -0.58% 3.95% 4.17%
ROA (Net income/ Total Assets) - -0.43% - - -21.4% -1.3% -0.3% -
Assets 1 - 6,116 - - 5,988 4,773 5,651 -
Book Value Per Share 2 - 7.830 8.580 8.950 - 5.720 5.690 5.690
Cash Flow per Share 2 - 1.270 1.350 1.300 0.8100 0.7200 0.8300 -
Capex 1 - 160 239 278 226 140 163 157
Capex / Sales - 3.24% 4.12% 4.61% 3.61% 2.28% 2.58% 2.43%
Announcement Date 10/2/20 3/18/21 3/8/22 3/22/23 3/13/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
1.51 USD
Average target price
2.996 USD
Spread / Average Target
+98.44%
Consensus
  1. Stock Market
  2. Equities
  3. WOOF Stock
  4. Financials Petco Health and Wellness Company, Inc.